GlaxoSmithKline CEO Continues Restructuring With Job Cuts in Africa Post author:Sam Post published:January 17, 2018 Post category:BioPharma This Latest move is a wide-ranging effort to boost competitiveness. Source: BioSpace You Might Also Like Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years September 14, 2017 FDA Approves 23andMe’s Direct-to-Consumer Genetic Test for Cancer March 6, 2018 <b>Embera Neurotherapeutics</b> To Present At The 2017 BIO Investor Forum October 12, 2017
Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years September 14, 2017
